ROARABLE
Today ⌘ Pro Terminal Big Ideas 🎲 Predictions Screener πŸ¦‹ Butterfly 8 Analysts πŸ›οΈ Policy 🎬 Video β˜… Watchlist 🎲 Prediction Markets πŸ“Š RQD Track Record πŸ“… Next Catalysts πŸ›‘οΈ Overlap & Crash X-Ray πŸ“° Live Wire πŸ‹ 13F Whales πŸ›οΈ Congress & CEO Buys πŸ† $100K Arena ⌘ Pro Terminal πŸ“ Methodology & Corrections
Stock Ratings / Health Care / HTFL / insiders
MMED (44) MMSI (68) STVN (54) HAE (74) ⌘ Pro Terminal β†’

Heartflow Inc. (HTFL) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$59.05 -2.44% NASDAQ β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $58.68

Heartflow Inc. (HTFL) carries a Roarable Rating of D+ (Sell) with 53/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

πŸ“Š Historical Track Record: Scores of 53/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.9% avg 90D alpha vs SPY) β†’
ROARABLE D+ β€’ SELL / AVOID Cap $5.13B
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on HTFL Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is HTFL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-03, Heartflow Inc. (NASDAQ: HTFL) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $59.05 (-2.44% 1D, market cap $5.13B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 18/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, HTFL ranks #228 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does HTFL compare to MMED and MMSI in the Health Care sector?
β–Ό

Within the Health Care sector (Medical/Dental Instruments), HTFL carries a Roarable D+ (53/100 RQD), trailing P/E of N/A, gross margin of 76.8%, and ROIC of -12.0%. By comparison, MMED (MiniMed Group Inc.) holds a D grade (44/100 RQD, P/E N/A, ROIC -3.9%, cap $5.14B) and MMSI (Merit Medical Systems Inc.) posts a C+ grade (68/100 RQD, P/E 43.4x, ROIC 7.8%, cap $5.17B). Among the 5-stock peer group, MMSI leads on earnings multiple (43.4x) while HAE leads on capital efficiency (8.4% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for HTFL?
β–Ό

Per HTFL's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001464521), Heartflow Inc. generated $176.0M in revenue (+39.9% YoY), -$116.8M in net income, and -$59.0M in free cash flow against $359.5M in total assets and $26.5M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $58.68 (-0.63%)🧬 Dilution Drag (+1.92% YoY Shares)βš™οΈ Cash Engine: 10/20 (D) β€’ 0% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record: Scores of 53/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.9% avg 90D alpha vs SPY β€’ 50.6% hit rate β€” wait for RQD β‰₯ 70 breakout).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERSELL / AVOID β€’ D+
025507510053
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ Β· Rk D
Cash (10)Whales (18)SEC (11)Macro (9)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-2.3% Base Target
$68 Bull$58 Base$45 Bear
πŸ“¬ FREE HTFL RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for HTFL)Realized 20D OHLCV Swing Band: Β±11.1%
Deterministic 5-Pillar Attribution (53/100 Composite)
πŸ” WHY HTFL SCORES 53/100 (D+) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: Whale & Options Positioning+18/20 pts (34% of score)

20D Institutional Volume Accumulation (Β±11.1% realized swing band)

β–² #2 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (21% of score)

Altman Z-Score 26.00 (FORTRESS SAFE (>3.0)) β€’ Piotroski F-Score 5/9

β–Ό #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)

Dilution Drag (+1.92% YoY Shares) & executive Form 4 sales trim 15 pts from alignment

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
45
Grade D$49.46+12.9% Next Q
Q2 (-2Q)
48
Grade D$55.82+5.9% Next Q
Q3 (-1Q)
50
Grade C-$59.10-0.1% Next Q
Current
53
Grade D+$59.05-0.9% Hist 90D Ξ±
Trajectory: D (45) β†’ D+ (53)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

βš”οΈ Adversarial Opposing Case: What Could Spark a HTFL Turnaround Squeeze

Gideon Ashmere Forensic Desk β†’

While HTFL currently carries a cautious 53/100 (D+) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

πŸš€ Contrarian Squeeze Trigger #1

Big institutional funds and options desks are actively positioning on the bullish side.

πŸš€ Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($51.43) and Max Pain ($62.00) forces dealer call-delta covering toward $68.11.

πŸš€ Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.92% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HTFLβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œHTFL Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 53%NO 47%Trade / Inspect Odds β†’
SEC FORM 4 Γ— 13F HEDGE FUNDS Γ— CONGRESSIONAL STOCK ACT

HTFL Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales β†’
β–² Disclosed Buys: 0 ($0)β–Ό Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (HTFL)

No recent open-market Form 4 cluster sales or emergency dumps flagged on HTFL. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring HTFL)

  • βœ“Walkthrough of HTFL's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) β†’$100K Arena
HTFL // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +103.97%⚑ TESTING RESISTANCE
2026-11-03O $60.53H $60.53L $59.05C $59.05VOL 2.25M
RES: $61.44SUP: $22.32SMA50: $51.43SMA200: $34.48
$63.13$52.49$41.85$31.21$20.57RES $61.44SUP $22.32$59.052026-05-042026-06-182026-08-052026-09-212026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HTFL Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

πŸ¦‹ HTFL Butterfly Map β†’ + Track HTFL β†’
Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
20.6%/yr Implied 5Y Growth

vs. +39.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on HTFL today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for HTFL. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for HTFL today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HTFL)

Health Care Rank #228 of 1016 βš”οΈ MMED vs HTFL Full Matrix β†’

1. Head-to-Head Health Care Peer Comparison (HTFL vs. MMED, MMSI, STVN, HAE)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Heartflow Inc. (HTFL) ranks #228 by composite RQD confidence (53/100, grade D+) and #161 by equity capitalization ($5.13B). Within this direct 5-issuer industry benchmark cohort, MMSI leads on earnings valuation at 43.4x trailing P/E, while HAE leads on capital efficiency and profitability with 8.4% ROIC and 59.0% gross margin. HAE currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with HTFL at 53/100 (D+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
HTFL ACTIVE
Heartflow Inc.
D+ 53/100 β€” 76.8% -12.0% -2.44% $5.13B Benchmark Subject
MMED
MiniMed Group Inc.
D 44/100 β€” 54.2% -3.9% -5.04% $5.14B /mmed-vs-htfl β†’
MMSI
Merit Medical Systems Inc.
C+ 68/100 43.4x 48.7% 7.8% -7.66% $5.17B /mmsi-vs-htfl β†’
STVN
Stevanato Group S.p.A.
D+ 54/100 β€” β€” β€” -4.25% $5.29B /stvn-vs-htfl β†’
HAE
Haemonetics Corporation
B 74/100 β€” 59.0% 8.4% -0.12% $5.44B /hae-vs-htfl β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0001464521

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Heartflow Inc. (HTFL) reported GAAP revenue of $176.0M (+39.9% vs. FY2024 revenue of $125.8M , and +101.9% cumulative change since FY2023) , GAAP net income of -$116.8M, operating cash flow of -$54.0M, and free cash flow of -$59.0M (+19.5% YoY). On the balance sheet, HTFL closed FY2025 with $359.5M in total assets against $26.5M in total debt (Altman Z-Score: 26.00, Piotroski F-Score: 5/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $176.0M -$116.8M -$54.0M -$59.0M $359.5M $26.5M
FY2024 (FY) 2024-12-31 $125.8M -$96.4M -$69.0M -$73.4M $118.7M $94.3M
FY2023 (FY) 2023-12-31 $87.2M -$95.7M -$76.4M -$80.4M $2.89B $677.4M

3. HTFL Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HTFL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Heartflow Inc. (NASDAQ: HTFL) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $59.05 (-2.44% 1D, market cap $5.13B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 18/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, HTFL ranks #228 in composite RQD confidence.

How does HTFL compare to MMED and MMSI in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), HTFL carries a Roarable D+ (53/100 RQD), trailing P/E of N/A, gross margin of 76.8%, and ROIC of -12.0%. By comparison, MMED (MiniMed Group Inc.) holds a D grade (44/100 RQD, P/E N/A, ROIC -3.9%, cap $5.14B) and MMSI (Merit Medical Systems Inc.) posts a C+ grade (68/100 RQD, P/E 43.4x, ROIC 7.8%, cap $5.17B). Among the 5-stock peer group, MMSI leads on earnings multiple (43.4x) while HAE leads on capital efficiency (8.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HTFL?

Per HTFL's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001464521), Heartflow Inc. generated $176.0M in revenue (+39.9% YoY), -$116.8M in net income, and -$59.0M in free cash flow against $359.5M in total assets and $26.5M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HTFL trading relative to its 50-day, 200-day, and 52-week technical levels?

HTFL last traded at $59.05 (-2.44% on volume of 2,247,387 shares), positioning the stock +14.82% above its 50-day simple moving average ($51.43) and +71.26% above its 200-day simple moving average ($34.48). Across its 52-week range of $20.13 to $60.56, HTFL sits at the 96.3% percentile with a 14-day RSI of 64.0 (BULLISH MOMENTUM) and an implied next-earnings move of Β±11.1% ($52.50 to $65.60).

HTFL Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

Are HTFL insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies HTFL leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

Direct Sub-Reports: HTFL RQD Cockpit HTFL 12M Forecast HTFL Earnings & Move HTFL Dividends & DRIP HTFL Insiders & 13F HTFL Whale Options HTFL Profit Sankey HTFL News & Why
ROARABLE RATING BRIEF β€’ RQD 53/100 (D+) βœ“ STAGE-C NUMBER FIREWALL VERIFIED

HTFL β€” Heartflow Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:20:29Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, HTFL scores 53 out of 100, a letter grade of D+, with the verdict "Roarable Sell β€” Weak Fundamentals / Trim." The five pillars are: Fundamental Cash Engine at 10 / 20 (ROIC of -12% and FCF yield of -1.12%); Whale 13F Flow at 18 / 20 (institutional accumulation and options positioning); Insider Conviction at 5 / 20 (SEC Form 4 and Congressional PTR cluster flow); Macro Regime Fit at 9 / 20 (Beta of 0.9 and sector sensitivity); and Forensic Balance Sheet at 11 / 20 (Altman Z-Score of 26, Piotroski F-Score of 5/9, Debt/Equity of 0.08).

For a prospective investor, the weakest pillars are the cash engine and insider conviction, while institutional flow is the strongest. The cash-generation pillar reflects negative ROIC and a negative FCF yield, meaning the business is not currently returning capital on its invested base per the source data. The balance-sheet pillar is comparatively supportive, with low leverage and a high Altman Z-Score, which suggests near-term solvency is not the principal concern in the source data. The insider pillar is low, indicating limited insider buying conviction in the cited flows. The upside case rests mainly on institutional positioning and any future improvement in cash generation; the valuation tradeoff is that the stock trades at a Forward P/E of 27 while reported EPS (TTM) is -1.34. The rating implies that the current price is not supported by present cash economics according to the RQD framework. This is an analytical read of the source data, not personalized financial advice.

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$176.0M$-64.1M$-116.8MN/A$-59.0M$44.8M$26.5M
FY 2024$125.8M$-61.2M$-96.4MN/A$-73.4M$51.4M$94.3M
FY 2023$87.2M$-72.9M$-95.7MN/A$-80.4MN/A$677.4M

Per the SEC financials, revenue rose from $87.2M in FY 2023 to $176.0M in FY 2025 while operating and net losses persisted in each period. Per the market data, operating margin is -36.4% and net margin is -60%, against a gross margin of 76.8%. ROIC is -12%. Per the Roarable RQD rating, the Altman Z-Score is 26, the Piotroski F-Score is 5/9, and Debt/Equity is 0.08; reported debt declined from $677.4M in FY 2023 to $26.5M in FY 2025.

Recent Catalysts & News Wire Analysis

Per the recent news and catalysts section, the headlines include: a Piper Sandler price-target raise citing a "competitive moat" (rated GREEN, CATALYST); a GuruFocus report on "Pivotal CT-Guided PCI Data at TCT Meeting" (YELLOW); and a Stock Titan item noting an officer proposal to sell 5,654 shares around October 22, 2026 (YELLOW). Other items from Yahoo! Finance Canada, Yahoo Finance Singapore, and TradingView are generic market-wire summaries (YELLOW) without specific catalyst content. Risk watch items include the insider share-sale proposal. Per the Butterfly Supply-Chain Graph, no supply-chain links or proprietary signals are present.

Open Questions

  • What is the company's specific product portfolio and revenue mix behind the 76.8% gross margin?
  • What is the source of the reported P/E (TTM) and EV/EBITDA gaps, and when will positive earnings be expected?
  • What is the EPS reported for FY 2023 through FY 2025, since the financials table lists EPS as N/A?
  • What is the cash balance for FY 2023, which is listed as N/A?
  • What do the named institutional and insider holders hold, given that the holders section is empty?

HTFL Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Heartflow Inc. (HTFL) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to HTFL Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

HTFL Bull vs. Bear Conversation Board β€” What's Your Call at $59.05?

πŸ‚ 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON HTFL 🐻 50% BEARISH CONVICTION
1. Pick Your Side on HTFL:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk βš–οΈ DEBATE HOST 🎯 Target: $65.37 (+8.0%)
πŸ“Œ Pinned Debate

πŸ”₯ Official Bull vs. Bear Debate: Is HTFL (D+ β€’ RQD 53/100) a Buy at $60.53?

Welcome to the HTFL (Heartflow Inc.) Roar Pit. Current RQD Composite is 53/100 (Roarable Sell β€” Weak Fundamentals / Trim) in Medical/Dental Instruments. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (πŸ‚ Bull or 🐻 Bear) and drop your price target below.

BE BearTrap_Alert Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $50.85 (-16.0%)
Spot @ $60.53

Pump the brakes on HTFL β€” check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on HTFL, but look at what you are paying: current EV/EBITDA multiples with 76.8% gross margins. Unless Heartflow Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

DE DeltaGamma_99 Verified K Arena Trader πŸ‚ BULLISH 🎯 Target: $75.06 (+24.0%)
Spot @ $60.53

HTFL cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on HTFL, the market is fixating on short-term headline noise in Medical/Dental Instruments and ignoring the balance sheet and cash flow trajectory. At $60.53 (52-wk range $20.13 - $60.56), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.35 -5.42% GLD $361.65 -3.59%